Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. (Q37914058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

Speranza Donatella Rubattu

9 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

Speranza Donatella Rubattu

9 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Massimo Volpe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Camilla Calvieri

1

1 reference

25 August 2017

publication date

9 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

5-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-011-0801-z

9 February 2020

exact match

0 references

cites work

Natriuretic peptides in cardiovascular diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Natriuretic peptides in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Calcineurin and hypertrophic heart disease: novel insights and remaining questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

The role of modulatory calcineurin-interacting proteins in calcineurin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

RGS4 inhibits G-protein signaling in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

TRPC channels are necessary mediators of pathologic cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Regulation of cardiac hypertrophy by intracellular signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

GATA4, a new regulator of cardiac fibroblasts, is sensitive to natriuretic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

The role of NHE-1 in myocardial hypertrophy and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Role of Na(+)-H+ exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Endothelin and angiotensin II stimulation of Na+-H+ exchange is impaired in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Chronic inhibition of the Na+/H+ - exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1–calcineurin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

TGF-beta1 and angiotensin networking in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

The role of TGF-beta signaling in myocardial infarction and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

TGF-beta signaling and the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Transforming growth factor-beta(1) expression in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Role of transforming growth factor-beta in the progression of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Myocardial production of C-type natriuretic peptide in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

NPR-C: a component of the natriuretic peptide family with implications in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

B-type natriuretic peptide infusions in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Combined neutral endopeptidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0801-Z

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma

21 January 2018

1 reference

12 December 2020

Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome

1 reference

12 December 2020

Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide

1 reference

12 December 2020

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

12 December 2020

Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells

1 reference

12 December 2020

Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.

1 reference

12 December 2020

C-type natriuretic peptide and cardiac fibrosis

1 reference

12 December 2020

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms

1 reference

12 December 2020

Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice

1 reference

12 December 2020

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

1 reference

12 December 2020

Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy

1 reference

12 December 2020

Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy

1 reference

12 December 2020

Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart

1 reference

12 December 2020

Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure

1 reference

12 December 2020

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.

1 reference

12 December 2020

Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena?

1 reference

12 December 2020

Angiotensin and endothelin: messengers that couple ventricular stretch to the Na+/H+ exchanger and cardiac hypertrophy

1 reference

12 December 2020

Transforming growth factor (TGF)-β signaling in cardiac remodeling.

1 reference

12 December 2020

C-type natriuretic peptide inhibits intimal thickening after vascular injury

1 reference

12 December 2020

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction

1 reference

12 December 2020

Role of TGF-beta on cardiac structural and electrical remodeling.

1 reference

12 December 2020

Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts

1 reference

12 December 2020

Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training

1 reference

12 December 2020

Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension

1 reference

12 December 2020

Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart

1 reference

12 December 2020

10.1007/S00109-011-0801-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826523%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference